BOGGIANI, Daniela

BOGGIANI, Daniela  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 1-gen-2019 Musolino, A; Cavanna, L; Boggiani, D; Zamagni, C; Frassoldati, A; Caldara, A; Rocca, A; Gori, S; Piacentini, F; Berardi, R; Brandes, Aa; Foglietta, J; Villa, F; Pellegrino, B; Todeschini, R; Tognetto, M; Naldi, N; Bortesi, B; Boni, L; Montemurro, F; Ardizzoni, A
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 1-gen-2021 Tommasi, Chiara; Pellegrino, Benedetta; Boggiani, Daniela; Sikokis, Angelica; Michiara, Maria; Uliana, Vera; Bortesi, Beatrice; Bonatti, Francesco; Mozzoni, Paola; Pinelli, Silvana; Squadrilli, Anna; Viani, Maria Vittoria; Cassi, Diana; Maglietta, Giuseppe; Meleti, Marco; Musolino, Antonino
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations 1-gen-2011 Tiseo, M.; Gelsomino, F.; Boggiani, D.; Bortesi, B.; Bartolotti, M.; Bozzetti, C.; Sammarelli, G.; Thai, E.; Ardizzoni, A.
Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review 1-gen-2019 Militello, A. M.; Zielli, T.; Boggiani, D.; Michiara, M.; Naldi, N.; Bortesi, B.; Zanelli, P.; Uliana, V.; Giuliotti, S.; Musolino, A.
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 1-gen-2017 Pellegrino, B.; Boggiani, D.; Tommasi, C.; Palli, D.; Musolino, A.
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 1-gen-2020 Pellegrino, B; Cavanna, L; Boggiani, D; Zamagni, C; Frassoldati, A; Schirone, A; Caldara, A; Rocca, A; Gori, S; Piacentini, F; Berardi, R; Brandes, A A; Foglietta, J; Villa, F; Todeschini, R; Tognetto, M; Naldi, N; Bortesi, B; Montemurro, F; Ardizzoni, A; Boni, L; Musolino, A
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 1-gen-2018 Musolino, Antonino; Falcini, F.; Sikokis, Angelica; Boggiani, Daniela; Rimanti, A.; Pellegrino, B.; Silini, E. M.; Campanini, N.; Barbieri, E.; Zamagni, C.; Degli Esposti, R.; Cortesi, Maria Luisa; Bisagni, GIUSEPPE ANDREA; Cavanna, L.; Frassoldati, A.; Sgargi, P.; Michiara, M.
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 1-gen-2016 Musolino, A; Sikokis, A; Boggiani, D; Rimanti, A; Pellegrino, B; Silini, Em; Campanini, N; Barbieri, E; Cortesi, L; Panebianco, M; Porzio, R; Frassoldati, A; Sgargi, P; Falcini, F; Michiara, M
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2 positive breast cancers 1-gen-2016 Musolino, A; Boggiani, Daniela; D;, Sikokis; A;, Rimanti; A;, Pellegrino; B;, Vattiato; R;, Sgargi; P;, Falcini; F;, Caminiti; C;, Michiara; M;, Leonardi; F,
Prognostic role of immunoglobulin g fragment c receptor polymorphisms in solid tumors 1-gen-2018 Viansone, A. A.; Boggiani, D.; Musolino, A.
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 1-gen-2022 Viansone, A; Pellegrino, B; Omarini, C; Pistelli, M; Boggiani, D; Sikokis, A; Uliana, V; Zanoni, D; Tommasi, C; Bortesi, B; Bonatti, F; Piacentini, F; Cortesi, L; Camisa, R; Sgargi, P; Michiara, M; Musolino, A
Risk of breast cancer in ovarian cancer patients non-carriers of BRCA1 and BRCA2 mutations with a family history of breast and ovarian cancer: A population-based cancer registry study 1-gen-2013 Musolino, A; Boggiani, D; Bella, Ma; Zanelli, P; Naldi, N; Bortesi, B; Sgargi, P; Michiara, M; Ardizzoni, A
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 1-gen-2020 Musolino, A.; Boggiani, D.; Pellegrino, B.; Zanoni, D.; Sikokis, A.; Missale, G.; Silini, E. M.; Maglietta, G.; Frassoldati, A.; Michiara, M.